IM-12 Tablets

IM-12 Tablets contain Ivermectin 12 mg and are formulated as an oral tablet dosage form for pharmaceutical use. Ivermectin is a semisynthetic compound belonging to the avermectin class of anthelmintic agents. The active pharmaceutical ingredient is presented in a solid oral dosage form, providing a defined 12 mg strength per tablet. IM-12 Tablets are developed as part of the anthelmintic product range and maintain a conventional tablet-based pharmaceutical presentation. The formulation combines the active ingredient with suitable pharmaceutical excipients to produce a consistent solid dosage form with appropriate physical characteristics for tablet manufacture. Ivermectin is a well-established pharmaceutical active ingredient used in oral formulations and is recognized for its broad-spectrum antiparasitic classification. IM-12 Tablets are supplied in a blister-pack presentation, with the product pack shown as 20 × 10 tablets. The product is intended for pharmaceutical and healthcare distribution through appropriate channels and should be handled, stored and supplied according to applicable pharmaceutical requirements and product specifications.